-logo.jpg "Saudi Pharmaceutical Industries (SPI)"){kind=logo}
Saudi Arabia
Saudi Pharmaceutical Industries (SPI), established in 1994, stands as a pioneering force in the Saudi Arabian pharmaceutical sector, particularly notable for being the first in the Kingdom to manufacture veterinary medicines. Headquartered in Riyadh, the company operates under the stringent regulations of the Ministry of Health and adheres to GMP quality standards, matching the quality benchmarks prevalent in Europe.
Under the leadership of Dr. Mohammed Ziadeh, SPI has successfully positioned itself as a frontrunner in the Health Care and Pharmaceutical industries, rivaling multinational corporations across the GCC and African markets. With a diverse and experienced team, the company manufactures an array of veterinary products and supplies to major local farms, including mineral blocks and vitamin premixes.
Despite its longstanding presence, Saudi Pharmaceutical Industries has not disclosed any recent investments, suggesting an opportunity for investors to engage with a well-established yet growth-ready entity in the emergent Middle Eastern pharmaceutical market.
